CODEPREX Drug Patent Profile
✉ Email this page to a colleague
When do Codeprex patents expire, and what generic alternatives are available?
Codeprex is a drug marketed by Lannett Co Inc and is included in one NDA.
The generic ingredient in CODEPREX is chlorpheniramine polistirex; codeine polistirex. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CODEPREX?
- What are the global sales for CODEPREX?
- What is Average Wholesale Price for CODEPREX?
Summary for CODEPREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | CODEPREX at DailyMed |
US Patents and Regulatory Information for CODEPREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett Co Inc | CODEPREX | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 021369-001 | Jun 21, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |